NPI registry status
Active
2026 NPPES data Rheumatology Physician NPI 1649586256 M.D.
Verify on CMS → Zeeshan Afzal, M.D.
Rheumatology Physician in El Paso, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,377 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
422
Medicare Part D claims · 60 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Zeeshan Afzal, M.D. filed 422 Medicare Part D claims in 2024 as a Rheumatology Physician in El Paso, Texas, prescribing 92% generic.
- 422
- Part D claims, 2024
- 92%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Zeeshan Afzal, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1649586256), first enumerated 08/20/2010.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 422 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Zeeshan Afzal, M.D.'s individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1649586256 · Rheumatology Physician
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1649586256
- ENUM-MID 2010
- TAX-MID 6K Rheumatology Physician
- RX-LIGHT 422
- BOOK-THIN 417 in Texas
- PHOTO-ENUM Basmah Jalil · 2010
Zeeshan Afzal, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
422 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Zeeshan Afzal, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Zeeshan Afzal, M.D.?
Quality data not reportedPrimary specialty
Rheumatology Physician
Medicare Part D claims
422 79% vs specialty avg
Specialty distribution in Texas
How Rheumatology Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Rheumatology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1649586256 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/20/2010 |
Hospital and facility affiliations
Facilities where Zeeshan Afzal, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Texas Tech University Health Sciences Center EL Paso
El Paso, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Zeeshan Afzal, M.D.. To verify Zeeshan Afzal, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Zeeshan Afzal, M.D. - brand share 8.0%
Rheumatology Physician average
8% brand-name claims vs 92% generic, on 422 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
422
Total Claims
$195K
Total Drug Cost
60
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 576.633
- Total Day Supply
- 17,078
- Brand vs Generic
- 8% brand / 92% generic
- Brand Drug Cost
- $188K
- Generic Drug Cost
- $7K
Patient Demographics
- Average Patient Age
- 72.1 years
- Avg HCC Risk Score
- 1.70
- Gender Split
- 80% female / 20% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Zeeshan Afzal, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Methotrexate
Methotrexate
129 claims
- Prednisone
Prednisone
73 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
67 claims
- Folic Acid 32
Folic Acid
32 claims
- Alendronate Sodium 20
Alendronate Sodium
20 claims
- Leflunomide 15
Leflunomide
15 claims
- Rinvoq 15
Rinvoq
15 claims
- Allopurinol 13
Allopurinol
13 claims
| Drug | Claims |
|---|---|
| Methotrexate Methotrexate Sodium | 129 |
| Prednisone | 73 |
| Hydroxychloroquine Sulfate | 67 |
| Folic Acid | 32 |
| Alendronate Sodium | 20 |
| Leflunomide | 15 |
| Rinvoq Upadacitinib | 15 |
| Allopurinol | 13 |
| Benlysta Belimumab | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Zeeshan Afzal, M.D. fits within the Rheumatology Physician landscape nationally.
6,377
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,058
Avg Claims per Provider
Zeeshan Afzal, M.D.'s 422 claims are below the specialty average of 2,058.
Nationwide Rheumatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Afzal, both outside Texas so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2010)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Rheumatology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Afzal.
One of 417 Rheumatology Physician providers enrolled in Texas, 5 are shown here.
Dr. Michael Abel
MD
Fredericksburg, TX
Dr. Tareq Abou-Khamis
M.D.
Houston, TX
Dr. Robert Abresch
M.D.
El Paso, TX
Dr. Sampada Acharya
MD
Fort Worth, TX
Dr. Waffiyah Afridi
M.D.
Farmers Branch, TX
Compare Rheumatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Zeeshan Afzal, M.D.'s specialty? ▼
Zeeshan Afzal, M.D. specializes in Rheumatology Physician and practices in El Paso, Texas. Credentials: M.D..
How much does Zeeshan Afzal, M.D. prescribe under Medicare Part D? ▼
In 2024, Zeeshan Afzal, M.D. wrote 422 Medicare Part D claims totaling $195K in drug costs for 60 beneficiaries.
Where is Zeeshan Afzal, M.D. located? ▼
Zeeshan Afzal, M.D. is located at 2000B TRANSMOUNTAIN RD STE B400, El Paso, TX, 79911. Phone: (915) 215-8523.
What is Zeeshan Afzal, M.D.'s NPI number? ▼
Zeeshan Afzal, M.D.'s National Provider Identifier (NPI) is 1649586256, issued on 08/20/2010.
Does Zeeshan Afzal, M.D. prescribe more brand-name or generic drugs? ▼
Zeeshan Afzal, M.D.'s prescribing is 8% brand-name and 92% generic drugs by claim count, with $188K in brand drug costs.
How many Rheumatology Physician providers are there in the US? ▼
There are 6,377 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,058 Medicare Part D claims per year.
What drugs does Zeeshan Afzal, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Zeeshan Afzal, M.D.'s most frequently prescribed drugs include Methotrexate, Prednisone, Hydroxychloroquine Sulfate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Zeeshan Afzal, M.D. accept Medicare? ▼
Zeeshan Afzal, M.D. appears in CMS Medicare data with 422 Part D claims and 60 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Zeeshan Afzal, M.D.'s credentials? ▼
Zeeshan Afzal, M.D.'s NPI is 1649586256 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.